Management of Physical Symptoms in Patients with Advanced Cancer during the Last Weeks and Days of Life

키워드

참고문헌 (131)

1. Dalal S, "End-of-life care matters : palliative cancer care results in better care and lower costs", Oncologist, 22, pp.361~368 (2017)
2. Portenoy RK, "Symptom prevalence, characteristics and distress in a cancer population", Qual Life Res, 3, pp.183~189 (1994)
3. Perez-Cruz PE, "Longitudinal temporal and probabilistic prediction of survival in a cohort of patients with advanced cancer", J Pain Symptom Manage, 48, pp.875~882 (2014)
4. Hui D, "Prognostication of survival in patients with advan-ced cancer : predicting the unpredictable?", Cancer Control, 22, pp.489~497 (2015)
5. Seow H, "Trajectory of performance status and symptom scores for patients with cancer during the last six months of life", J Clin Oncol, 29, pp.1151~1158 (2011)
6. Williams AL, "Cancer family caregivers during the palliative, hospice, and bereavement phases : a review of the descriptive psychosocial literature", Palliat Support Care, 9, pp.315~325 (2011)
7. Gaertner J, "Palliative care consultation service and palliative care unit : why do we need both?", Oncologist, 17, pp.428~435 (2012)
8. Elsayem A, "A month in an acute palliative care unit : clinical interventions and financial outcomes", Am J Hosp Palliat Care, 28, pp.550~555 (2011)
9. Hui D, "Availability and integration of palliative care at US cancer centers", JAMA, 303, pp.1054~1061 (2010)
10. Tayjasanant S, "How far along the disease trajectory? An examination of the time-related patient characteristics in the palliative oncology literature", Support Care Cancer, 24, pp.3997~4004 (2016)
11. Portenoy RK, "Cancer pain : epidemiology and syndromes", Cancer, 63(11 Suppl), pp.2298~2307 (1989)
12. Goudas LC, "The epidemiology of cancer pain", Cancer Invest, 23, pp.182~190 (2005)
13. van den Beuken-van Everdingen MH, "Update on prevalence of pain in patients with cancer : systematic review and meta-analysis", J Pain Symptom Manage, 51, pp.1070~1090 (2016)
14. Dalal S, "State of art of managing pain in patients with cancer", Cancer J, 19, pp.379~389 (2013)
15. Strasser F, "Palliative pain management : when both pain and suffering hurt", J Palliat Care, 21, pp.69~79 (2005)
16. Cleeland CS, "Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory", Cancer, 89, pp.1634~1646 (2000)
17. Bruera E, "The Edmonton Symptom Assessment System(ESAS) : a simple method for the assessment of palliative care patients", J Palliat Care, 7, pp.6~9 (1991)
18. Hui D, "A personalized approach to assessing and managing pain in patients with cancer", J Clin Oncol, 32, pp.1640~1646 (2014)
19. Mayfield D, "The CAGE questionnaire : validation of a new alcoholism screening instrument", Am J Psychiatry, 131, pp.1121~1123 (1974)
20. Finkelman MD, "Cross-validation of short forms of the Screener and Opioid Assessment for Patients with Pain-Revised(SOAPP-R)", Drug Alcohol Depend, 178, pp.94~100 (2017)
21. Kim YJ, "Association between tobacco use, symptom expression, and alcohol and illicit drug use in advanced cancer patients", J Pain Symptom Manage, 51, pp.762~768 (2016)
22. Dev R, "Undocumented alcoholism and its correlation with tobacco and illegal drug use in advanced cancer patients", Cancer, 117, pp.4551~4556 (2011)
23. Hui D, "The Edmonton symptom assessment system 25 years later : past, present, and future developments", J Pain Symptom Manage, 53, pp.630~643 (2017)
24. Hui D, "Personalized symptom goals and response in patients with advanced cancer", Cancer, 122, pp.1774~1781 (2016)
25. Dalal S, "Achievement of personalized pain goal in cancer patients referred to a supportive care clinic at a comprehensive cancer center", Cancer, 118, pp.3869~3877 (2012)
26. Arthur J, "Personalized pain goal as an outcome measure in routine cancer pain assessment", J Pain Symptom Manage, 56, pp.80~87 (2018)
27. Grossman SA, "Correlation of patient and caregiver ratings of cancer pain", J Pain Symptom Manage, 6, pp.53~57 (1991)
28. Lopez G, "The effects of inpatient music therapy on self-reported symptoms at an academic cancer center : a preliminary report", Support Care Cancer, 27, pp.4207~4212 (2019)
29. He Y, "Clinical evidence for association of acupuncture and acupressure with improved cancer pain : a systematic review and meta-analysis", JAMA Oncol, 6, pp.271~278 (2020)
30. Alimi D, "Analgesic effect of auricular acupuncture for cancer pain : a randomized, blinded, controlled trial", J Clin Oncol, 21, pp.4120~4126 (2003)
31. Paley CA, "Acupuncture for cancer pain in adults", Cochrane Database Syst Rev, 2015, pp.CD007753~ (2015)
32. Standish LJ, "Acupuncture is underutilized in hospice and palliative medicine", Am J Hosp Palliat Care, 25, pp.298~308 (2008)
33. Portenoy RK, "Treatment of cancer pain", Lancet, 377, pp.2236~2247 (2011)
34. Caraceni A, "Use of opioid analgesics in the treatment of cancer pain : evidence-based recommendations from the EAPC", Lancet Oncol, 13, pp.e58~e68 (2012)
35. "NCCN guidelines for adult cancer pain, version 1.2022" (2022)[URL]
36. Bruera E, "Textbook of palliative medicine and supportive care" (2021), CRC Press
37. Ripamonti C, "Rectal, buccal, and sublingual narcotics for the management of cancer pain", J Palliat Care, 7, pp.30~35 (1991)
38. De Conno F, "Role of rectal route in treating cancer pain : a randomized crossover clinical trial of oral versus rectal morphine administration in opioid-naive cancer patients with pain", J Clin Oncol, 13, pp.1004~1008 (1995)
39. Bruera E, "Clinical efficacy and safety of a novel controlled-release morphine suppository and subcutaneous morphine in cancer pain : a randomized evaluation", J Clin Oncol, 13, pp.1520~1527 (1995)
40. Hanks GW, "Morphine and alternative opioids in cancer pain : the EAPC recommendations", Br J Cancer, 84, pp.587~593 (2001)
41. Bruera E, "Changing pattern of agitated impaired mental status in patients with advanced cancer : association with cognitive monitoring, hydration, and opioid rotation", J Pain Symptom Manage, 10, pp.287~291 (1995)
42. Smith MT, "Neuroexcitatory effects of morphine and hydromorphone : evidence implicating the 3-glucuronide metabolites", Clin Exp Pharmacol Physiol, 27, pp.524~528 (2000)
43. Lim KH, "Frequency, outcomes, and associated factors for opioid-induced neurotoxicity in patients with advanced cancer receiving opioids in inpatient palliative care", J Palliat Med, 21, pp.1698~1704 (2018)
44. Bruera E, "Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone, and morphine", Cancer, 78, pp.852~857 (1996)
45. Mercadante S, "Opioid switching in cancer pain : from the beginning to nowadays", Crit Rev Oncol Hematol, 99, pp.241~248 (2016)
46. Lossignol D, "A little help from steroids in oncology", J Transl Int Med, 4, pp.52~54 (2016)
47. European Delirium Association, "The DSM-5 criteria, level of arousal and delirium diagnosis: inclusiveness is safer", BMC Med, 12, pp.141~ (2014)
48. Lawlor PG, "Occurrence, causes, and outcome of delirium in patients with advanced cancer : a prospective study", Arch Intern Med, 160, pp.786~794 (2000)
49. Tuma R, "Altered mental status in patients with cancer", Arch Neurol, 57, pp.1727~1731 (2000)
50. Hosie A, "Delirium prevalence, incidence, and implications for screening in specialist palliative care inpatient settings : a systematic review", Palliat Med, 27, pp.486~498 (2013)
51. Caraceni A, "Impact of delirium on the short term prognosis of advanced cancer patients. Italian Multicenter Study Group on Palliative Care", Cancer, 89, pp.1145~1149 (2000)
52. de la Cruz M, "The frequency, characteristics, and outcomes among cancer patients with delirium admitted to an acute palliative care unit", Oncologist, 20, pp.1425~1431 (2015)
53. Wada T, "Characteristics, interventions, and outcomes of misdiagnosed delirium in cancer patients", Palliat Support Care, 8, pp.125~131 (2010)
54. de la Cruz M, "The frequency of missed delirium in patients referred to palliative care in a comprehensive cancer center", Support Care Cancer, 23, pp.2427~2433 (2015)
55. Bruera E, "Management of specific symptom complexes in patients receiving palliative care", CMAJ, 158, pp.1717~1726 (1998)
56. Moyer DD, "Review article : terminal delirium in geriatric patients with cancer at end of life", Am J Hosp Palliat Care, 28, pp.44~51 (2011)
57. Inouye SK, "Clarifying confusion : the confusion assessment method : a new method for detection of delirium", Ann Intern Med, 113, pp.941~948 (1990)
58. Adamis D, "Reliability of Delirium Rating Scale(DRS)and Delirium Rating Scale-Revised-98(DRS-R98)using variance-based multivariate modelling", J Psychiatr Res, 47, pp.966~971 (2013)
59. Breitbart W, "The Memorial Delirium Assessment Scale", J Pain Symptom Manage, 13, pp.128~137 (1997)
60. Lawlor PG, "Clinical utility, factor analysis, and further validation of the memorial delirium assessment scale in patients with advanced cancer : assessing delirium in advan-ced cancer", Cancer, 88, pp.2859~2867 (2000)
61. Gagnon P, "Delirium in advanced cancer : a psychoeducational intervention for family caregivers", J Palliat Care, 18, pp.253~261 (2002)
62. Clegg A, "Which medications to avoid in people at risk of delirium : a systematic review", Age Ageing, 40, pp.23~29 (2011)
63. Breitbart W, "Evidence-based treatment of delirium in patients with cancer", J Clin Oncol, 30, pp.1206~1214 (2012)
64. Hshieh TT, "Effectiveness of multicomponent nonpharmacological delirium interventions : a meta-analysis", JAMA Intern Med, 175, pp.512~520 (2015)
65. Hosie A, "A multicomponent nonpharmacological intervention to prevent delirium for hospitalized people with advanced cancer : a phase II cluster randomized waitlist controlled trial(The PRESERVE Pilot Study)", J Palliat Med, 23, pp.1314~1322 (2020)
66. Gagnon P, "Delirium prevention in terminal cancer : assessment of a multicomponent intervention", Psychooncology, 21, pp.187~194 (2012)
67. Agar MR, "Efficacy of oral risperidone, haloperidol, or placebo for symptoms of delirium among patients in palliative care : a randomized clinical trial", JAMA Intern Med, 177, pp.34~42 (2017)
68. Hui D, "Neuroleptic strategies for terminal agitation in patients with cancer and delirium at an acute palliative care unit : a single-centre, double-blind, parallel-group, randomised trial", Lancet Oncol, 21, pp.989~998 (2020)
69. Hui D, "Benzodiazepines for agitation in patients with delirium : selecting the right patient, right time, and right indication", Curr Opin Support Palliat Care, 12, pp.489~494 (2018)
70. Hui D, "Effect of lorazepam with haloperidol vs haloperidol alone on agitated delirium in patients with advanced cancer receiving palliative care : a randomized clinical trial", JAMA, 318, pp.1047~1056 (2017)
71. Hui D, "The minimal clinically important difference of the Richmond Agitation-Sedation Scale in patients with cancer with agitated delirium", Cancer, 124, pp.2246~2252 (2018)
72. Tang M, "Association among rescue neuroleptic use, agitation, and perceived comfort : secondary analysis of a randomized clinical trial on agitated delirium", Support Care Cancer, 29, pp.7887~7894 (2021)
73. Bruera E, "Palliative sedation : when and how?", J Clin Oncol, 30, pp.1258~1259 (2012)
74. Prado BL, "Continuous palliative sedation for patients with advanced cancer at a tertiary care cancer center", BMC Palliat Care, 17, pp.13~ (2018)
75. Maltoni M, "Palliative sedation in end-of-life care and survival : a systematic review", J Clin Oncol, 30, pp.1378~1383 (2012)
76. Elsayem A, "Use of palliative sedation for intractable symptoms in the palliative care unit of a comprehensive cancer center", Support Care Cancer, 17, pp.53~59 (2009)
77. Del Fabbro E, "Palliative sedation : when the family and consulting service see no alternative", J Palliat Med, 10, pp.488~492 (2007)
78. Cherny NI, "European Association for Palliative Care(EAPC)recommended framework for the use of sedation in palliative care", Palliat Med, 23, pp.581~593 (2009)
79. Mount BM, "The problem of caring for the dying in a general hospital : the palliative care unit as a possible solution", Can Med Assoc J, 115, pp.119~121 (1976)
80. 신성훈, "Frequency and Outcome of Neuroleptic Rotation in the Management of Delirium in Patients with Advanced Cancer", Cancer Research and Treatment, 47(3), pp.399~405 (2015), 대한암학회[DOI]
81. Dyspnea, "Mechanisms, assessment, and management: a consensus statement", Am J Respir Crit Care Med, 159, pp.321~340 (1999), American Thoracic Society
82. Reddy SK, "Characteristics and correlates of dyspnea in patients with advanced cancer", J Palliat Med, 12, pp.29~36 (2009)
83. Dudgeon DJ, "Dyspnea in the advanced cancer patient", J Pain Symptom Manage, 16, pp.212~219 (1998)
84. Dudgeon DJ, "Physiological changes and clinical correlations of dyspnea in cancer outpatients", J Pain Symptom Manage, 21, pp.373~379 (2001)
85. Bruera E, "The frequency and correlates of dyspnea in patients with advan-ced cancer", J Pain Symptom Manage, 19, pp.357~362 (2000)
86. Tanaka K, "Factors correlated with dyspnea in advanced lung cancer patients : organic causes and what else?", J Pain Symptom Manage, 23, pp.490~500 (2002)
87. Reuben DB, "Dyspnea in terminally ill cancer patients", Chest, 89, pp.234~236 (1986)
88. Hui D, "Symptom expression in the last seven days of life among cancer pati-ents admitted to acute palliative care units", J Pain Symptom Manage, 50, pp.488~494 (2015)
89. Mori M, "Unanswered questions and future direction in the management of terminal breathlessness in patients with cancer", ESMO Open, 1, pp.e000603~ (2020)
90. Mularski RA, "Quality of dying in the ICU : ratings by family members", Chest, 128, pp.280~287 (2005)
91. Hui D, "Dyspnea in hospitalized advanced cancer patients : subjective and physiologic correlates", J Palliat Med, 16, pp.274~280 (2013)
92. Campbell ML, "A Respiratory Distress Observation Scale for patients unable to self-report dyspnea", J Palliat Med, 13, pp.285~290 (2010)
93. Mularski RA, "An official American Thoracic Society workshop report : assessment and palliative management of dyspnea crisis", Ann Am Thorac Soc, 10, pp.S98~S106 (2013)
94. Hui D, "Management of dyspnea in advanced cancer : ASCO guideline", J Clin Oncol, 39, pp.1389~1411 (2021)
95. Galbraith S, "Does the use of a handheld fan improve chronic dyspnea? A randomized, controlled, crossover trial", J Pain Symptom Manage, 39, pp.831~838 (2010)
96. Bausewein C, "Effectiveness of a hand-held fan for breathlessness : a randomised phase II trial", BMC Palliat Care, 9, pp.22~ (2010)
97. Wong SL, "The effect of using an electric fan on dyspnea in Chinese patients with terminal cancer", Am J Hosp Palliat Care, 34, pp.42~46 (2017)
98. Pisani L, "Management of dyspnea in the terminally ill", Chest, 154, pp.925~934 (2018)
99. Jennings AL, "A systematic review of the use of opioids in the management of dyspnoea", Thorax, 57, pp.939~944 (2002)
100. Mahler DA, "Opioids for refractory dyspnea", Expert Rev Respir Med, 7, pp.123~134 (2013)
101. Mazzocato C, "The effects of morphine on dyspnea and ventilatory function in elderly patients with advanced cancer : a randomized double-blind controlled trial", Ann Oncol, 10, pp.1511~1514 (1999)
102. Barnes H, "Opioids for the palliation of refractory breathlessness in adults with advanced disease and terminal illness", Cochrane Database Syst Rev, 3, pp.CD011008~ (2016)
103. Del Fabbro E, "Symptom control in palliative care, Part III : dyspnea and delirium", J Palliat Med, 9, pp.422~436 (2006)
104. Simon ST, "Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults", Cochrane Database Syst Rev, 10, pp.CD007354~ (2016)
105. Navigante AH, "Morphine versus midazolam as upfront therapy to control dyspnea perception in cancer patients while its underlying cause is sought or treated", J Pain Symptom Manage, 39, pp.820~830 (2010)
106. Hui D, "High-flow oxygen and bilevel positive airway pressure for persistent dyspnea in patients with advanced cancer : a phase II randomized trial", J Pain Symptom Manage, 46, pp.463~473 (2013)
107. Wilcock A, "Randomised, placebo controlled trial of nebulised furosemide for breathlessness in patients with cancer", Thorax, 63, pp.872~875 (2008)
108. Hui D, "High-flow oxygen and high-flow air for dyspnea in hospitalized patients with cancer : a pilot crossover randomized clinical trial", Oncologist, 26, pp.e883~e892 (2021)
109. Lokker ME, "Prevalence, impact, and treatment of death rattle : a systematic review", J Pain Symptom Manage, 47, pp.105~122 (2014)
110. Hui D, "Clinical signs of impending death in cancer patients", Oncologist, 19, pp.681~687 (2014)
111. Morita T, "A prospective study on the dying process in terminally ill cancer pati-ents", Am J Hosp Palliat Care, 15, pp.217~222 (1998)
112. Mercadante S, "Refractory death rattle : deep aspiration facilitates the effects of antisecretory agents", J Pain Symptom Manage, 41, pp.637~639 (2011)
113. van Esch HJ, "Understanding relatives’ experience of death rattle", BMC Psychol, 8, pp.62~ (2020)
114. Wee BL, "The sound of death rattle II : how do relatives interpret the sound?", Palliat Med, 20, pp.177~181 (2006)
115. Wee BL, "The sound of death rattle I : are relatives distressed by hearing this sound?", Palliat Med, 20, pp.171~175 (2006)
116. Campbell ML, "Death rattle is not associated with patient respiratory distress : is pharmacologic treatment indicated?", J Palliat Med, 16, pp.1255~1259 (2013)
117. Wee B, "Interventions for noisy breathing in pati-ents near to death", Cochrane Database Syst Rev, 2008, pp.CD005177~ (2008)
118. Clark K, "A pilot phase II randomized, cross-over, double-blinded, controlled efficacy study of octreotide versus hyoscine hydrobromide for control of noisy breathing at the end-of-life", J Pain Palliat Care Pharmacother, 22, pp.131~138 (2008)
119. Heisler M, "Randomized double-blind trial of sublingual atropine vs. placebo for the management of death rattle", J Pain Symptom Manage, 45, pp.14~22 (2013)
120. Mercadante S, "Hyoscine butylbromide for the management of death rattle : sooner rather than later", J Pain Symptom Manage, 56, pp.902~907 (2018)
121. van Esch HJ, "Effect of prophylactic subcutaneous scopolamine butylbromide on death rattle in patients at the end of life : the SILENCE randomized clinical trial", JAMA, 326, pp.1268~1276 (2021)
122. Likar R, "Efficacy of glycopyrronium bromide and scopolamine hydrobromide in patients with death rattle : a randomized controlled study", Wien Klin Wochenschr, 120, pp.679~683 (2008)
123. Wildiers H, "Atropine, hyoscine butylbromide, or scopolamine are equally effective for the treatment of death rattle in terminal care", J Pain Symptom Manage, 38, pp.124~133 (2009)
124. Kintzel PE, "Anticholinergic medications for managing noisy respirations in adult hospice patients", Am J Health Syst Pharm, 66, pp.458~464 (2009)
125. Prommer E, "Anticholinergics in palliative medicine : an update", Am J Hosp Palliat Care, 30, pp.490~498 (2013)
126. Koekkoek JA, "Antiepileptic drug treatment in the end-of-life phase of glioma patients : a feasibility study", Support Care Cancer, 24, pp.1633~1638 (2016)
127. Mercadante S, "Opioid analgesics adverse effects : the other side of the coin", Curr Pharm Des, 25, pp.3197~3202 (2019)
128. Haut SR, "Benzodiazepine use in seizure emergencies : a systematic review", Epilepsy Behav, 63, pp.109~117 (2016)
129. Hui D, "Internal medicine issues in palliative cancer care" (2014), Oxford University Press
130. Jain P, "Efficacy and safety of anti-epileptic drugs in patients with active convulsive seizures when no IV access is available : systematic review and meta-analysis", Epilepsy Res, 122, pp.47~55 (2016)
131. Zelcer M, "Intranasal midazolam for seizure cessation in the community setting", Can Fam Physician, 62, pp.559~561 (2016)

관련 논문AI추천